Cargando…
Aspects cliniques, physiopathologiques, et thérapeutiques de la sclérose en plaques
Multiple sclerosis (MS) is characterized by multiple demyelinating lesions disseminated in the central nervous system. The clinical course of MS involves acute attacks leading to permanent disability and a chronic progressive stage occurring at the beginning of the disease or after a relapsing-remit...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Éditions scientifiques et médicales Elsevier SAS.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148977/ http://dx.doi.org/10.1016/j.emcn.2004.05.002 |
_version_ | 1783520713353723904 |
---|---|
author | Ouallet, J.-C. Brochet, B. |
author_facet | Ouallet, J.-C. Brochet, B. |
author_sort | Ouallet, J.-C. |
collection | PubMed |
description | Multiple sclerosis (MS) is characterized by multiple demyelinating lesions disseminated in the central nervous system. The clinical course of MS involves acute attacks leading to permanent disability and a chronic progressive stage occurring at the beginning of the disease or after a relapsing-remitting phase. Investigations that provide supportive evidence for the diagnosis of MS are magnetic resonance imaging and cerebrospinal fluid examination. Recent pathological studies showed evidence of early axonal pathology, remyelination in some cases, and diffuse pathology. Genetic and immunological studies suggest that MS is an auto-immune disease, partially genetically determined but the role of an environmental factor, possibly infectious is possible. Cumulative evidence of the efficacy of interferon beta and other disease-modifying drug therapy has completely modified the therapeutic approach of MS. |
format | Online Article Text |
id | pubmed-7148977 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | Éditions scientifiques et médicales Elsevier SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71489772020-04-13 Aspects cliniques, physiopathologiques, et thérapeutiques de la sclérose en plaques Ouallet, J.-C. Brochet, B. EMC - Neurologie Article Multiple sclerosis (MS) is characterized by multiple demyelinating lesions disseminated in the central nervous system. The clinical course of MS involves acute attacks leading to permanent disability and a chronic progressive stage occurring at the beginning of the disease or after a relapsing-remitting phase. Investigations that provide supportive evidence for the diagnosis of MS are magnetic resonance imaging and cerebrospinal fluid examination. Recent pathological studies showed evidence of early axonal pathology, remyelination in some cases, and diffuse pathology. Genetic and immunological studies suggest that MS is an auto-immune disease, partially genetically determined but the role of an environmental factor, possibly infectious is possible. Cumulative evidence of the efficacy of interferon beta and other disease-modifying drug therapy has completely modified the therapeutic approach of MS. Éditions scientifiques et médicales Elsevier SAS. 2004-10 2004-07-29 /pmc/articles/PMC7148977/ http://dx.doi.org/10.1016/j.emcn.2004.05.002 Text en Copyright © 2004 Éditions scientifiques et médicales Elsevier SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ouallet, J.-C. Brochet, B. Aspects cliniques, physiopathologiques, et thérapeutiques de la sclérose en plaques |
title | Aspects cliniques, physiopathologiques, et thérapeutiques de la sclérose en plaques |
title_full | Aspects cliniques, physiopathologiques, et thérapeutiques de la sclérose en plaques |
title_fullStr | Aspects cliniques, physiopathologiques, et thérapeutiques de la sclérose en plaques |
title_full_unstemmed | Aspects cliniques, physiopathologiques, et thérapeutiques de la sclérose en plaques |
title_short | Aspects cliniques, physiopathologiques, et thérapeutiques de la sclérose en plaques |
title_sort | aspects cliniques, physiopathologiques, et thérapeutiques de la sclérose en plaques |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148977/ http://dx.doi.org/10.1016/j.emcn.2004.05.002 |
work_keys_str_mv | AT oualletjc aspectscliniquesphysiopathologiquesettherapeutiquesdelascleroseenplaques AT brochetb aspectscliniquesphysiopathologiquesettherapeutiquesdelascleroseenplaques |